Nobel Biocare Holding AG's quarterly market cap
declined
from Dec. 2011 (CHF1,337.5 Mil) to Dec. 2012 (CHF960.6 Mil) but then
increased
from Dec. 2012 (CHF960.6 Mil) to Dec. 2013 (CHF1,704.5 Mil).
Nobel Biocare Holding AG's annual market cap
declined
from Dec. 2011 (CHF1,337.5 Mil) to Dec. 2012 (CHF960.6 Mil) but then
increased
from Dec. 2012 (CHF960.6 Mil) to Dec. 2013 (CHF1,704.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nobel Biocare Holding AG's Enterprise Value for Today is CHF2,082.0 Mil.
Nobel Biocare Holding AG Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nobel Biocare Holding AG's Market Cap
For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobel Biocare Holding AG's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Nobel Biocare Holding AG's Market Cap falls into.
Nobel Biocare Holding AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nobel Biocare Holding AG's Market Cap for the fiscal year that ended in Dec. 2013 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nobel Biocare Holding AG (XSWX:NOBN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nobel Biocare Holding AG Market Cap Related Terms
Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Nobel Biocare Holding AG (XSWX:NOBN) Business Description
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:NOBN has been successfully added to your 